ArticleFrontiers in medicine2022

A new small molecule DHODH-inhibitor [KIO-100 (PP-001)] targeting activated T cells for intraocular treatment of uveitis - A phase I clinical trial.

Stephan Thurau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.